| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |